Morepen Laboratories announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 18 March 2024 .Powered by Capital Market - Live News

Net profit of Morepen Laboratories rose 255.84% to Rs 31.99 crore in the quarter ended December 2023 as against Rs 8.99 crore during the previous quarter ended December 2022. Sales rose 27.57% to Rs 444.55 crore in the quarter ended December 2023 as against Rs 348.47 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales444.55348.47 28 OPM %11.385.89 - PBDT52.4721.19 148 PBT44.0214.00 214 NP31.998.99 256 Powered by Capital Market - Live News

Morepen Laboratories will hold a meeting of the Board of Directors of the Company on 31 January 2024.Powered by Capital Market - Live News

Net profit of Morepen Laboratories rose 34.47% to Rs 21.26 crore in the quarter ended September 2023 as against Rs 15.81 crore during the previous quarter ended September 2022. Sales rose 4.66% to Rs 421.77 crore in the quarter ended September 2023 as against Rs 402.98 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales421.77402.98 5 OPM %7.967.17 - PBDT36.3729.31 24 PBT28.6822.31 29 NP21.2615.81 34 Powered by Capital Market - Live News

Morepen Laboratories will hold a meeting of the Board of Directors of the Company on 2 November 2023.Powered by Capital Market - Live News